Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation

The clinical implementation of magnetic hyperthermia has experienced little progress since the first clinical trial was completed in 2005. Some of the hurdles to overcome are the reliable production of magnetic nanoparticles with controlled properties and the control of the temperature at the target...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Yurena Luengo, Zamira V. Díaz-Riascos, David García-Soriano, Francisco J. Teran, Emilio J. Artés-Ibáñez, Oihane Ibarrola, Álvaro Somoza, Rodolfo Miranda, Simó Schwartz, Ibane Abasolo, Gorka Salas
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2022-07-01
Σειρά:	Pharmaceutics
Θέματα:	magnetic hyperthermia cancer nanoparticles controlled heat in vivo
Διαθέσιμο Online:	https://www.mdpi.com/1999-4923/14/8/1526
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!